Company / Free Cash Flow per Share
Olema Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.78
FY2024
5-year range
-$2.84 / -$1.32
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#128 of 192
Health Care
What the data says
At $-1.78, Olema Pharmaceuticals, Inc.'s free cash flow per share ranks #128 of 192 in the Health Care sector. Declined from $-1.32 to $-1.78 over the past 3 years.
Based on SEC 10-K filings.
-1.78 in FY2024.
Declined from $-1.32 to $-1.78 over the past 3 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#128 of 192 in Health CareTop 67% of 192This company -$1.78 Sector average -$19.84
▼
+91.0% above sector average
Key checks
Key Insights
- Ranks #128 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.78 | - |
| FY2023 | - | - |
| FY2022 | -$2.06 | -55.9% |
| FY2021 | -$1.32 | +53.4% |
| FY2020 | -$2.84 | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026